Quick Chat with Roland Jbeily, Regulatory Affairs Manager

Altasciences’ Regulatory Affairs team has significant expertise with regulatory bodies in both the U.S. and Canada. In this interview, Roland Jbeily discusses how our Canadian operations works as a bridge between sponsors and Health Canada providing strategic guidance to colleagues and sponsors to help advance drug development with speed and ease.

Watch the full interview and get through the CTA process with confidence: ​​​​​

Watch video

You may also be interested in the following:

• Integrated Research Services
• Webinar — Discovering the Many Advantages of Conducting Early Phase Clinical Trials in North America
• The Altascientist — Planning Your First-in-Human Trial

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Seamless Bioanalytical Transition

Altasciences’ scientists move in unison with you, collaboratively, accurately, and efficiently, from preclinical to clinical, and beyond. Our team of over 260 bioanalytical scientific veterans is strategically located across North America, and has experience with a wide spectrum of biological matrices in both animal and humans.
 
Driven by your assay requirements, our program support includes LC-MS/MS, LBA OR HYBRID LBA/LC-MS/MS ASSAY platforms for:

Speak with a scientist

Have 5 minutes? You may also be interested in the following:

• Assay List — Over 685 Assays covering 650 Molecules
• The Altascientist — Validation of Immunogenicity Assays
• Webinar — Development of a Cell-Based Assay for Dual Purposes: to Support Drug Potency and Immunogenicity Characterization

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.

PODCAST — How Novel Data-Driven Treatments Are Improving Patient Care

Special guest Dr. Michael Winlo, Managing Director at Emyria, joins us for a very insightful conversation about their unique programs and new patient care models. Emyria is a biotech company that brings together patients, clinicians, researchers, and medical innovators to develop data-driven, novel treatments for patients in need, including cannibidiol formulations.

Listen now!

Have questions? Speak with one of our experts.

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

Altasciences’ preclinical and clinical sites share the same validation of instrumentation and panels to ensure a smooth transition. Our flow cytometry labs are located near our clinical pharmacology units, for rapid turnaround between sample collection and analysis.

Let’s schedule a conversation to review your program needs.

Speak with an expert

You may also be interested in the following:

• Four Reasons to Choose Altasciences as Your Flow Cytometry Partner
• Flow Cytometry Capabilities
• Comprehensive Clinical Trial Services
• Preclinical Services

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.